Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story Our Unit


CHDR and LUMC receive a €1.9 million grant to study the use of medicinal cannabi...

23 Dec 2020

Proof of pharmacology of Org 48775-0, a p38 MAP kinase inhibitor, in healthy vol...

17 Nov 2020

Interested to join our team? Browse the latest openings

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

Finding biomarkers to predict clinical success

Providing clients with customised data management solutions for clinical trials

Pre-screened patients on standby for early-stage clinical trials